drugset / Trial / NCT02188186
Therapeutic Efficacy of Triple Combination in Drug-naïve Korean Type 2 Diabetic Patients
RandomizedParallel-groupTriple-blindTreatment
Summary
Triple combination of metformin, DPP4 inhibitor and Thiazolidinedione would be a good option in the treatment of drug-naïve Korean type 2 diabetic patients.
Timeline
- Start
- 2014-07
- Primary completion
- 2018-09
- Completion
- 2018-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lobeglitazone | Small molecule | 0.5 mg | — |
| Subject | Metformin | Small molecule | — | — |
| Subject | Sitagliptin | Small molecule | 100 mg | — |